4/16
04:30 pm
cvrx
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
Medium
Report
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
4/15
07:48 am
cvrx
CVRx announces availability of additional data supporting long-term benefits of Barostim [Yahoo! Finance]
Medium
Report
CVRx announces availability of additional data supporting long-term benefits of Barostim [Yahoo! Finance]
4/15
07:30 am
cvrx
CVRx announces availability of additional data supporting long-term benefits of Barostim
Medium
Report
CVRx announces availability of additional data supporting long-term benefits of Barostim
2/6
08:19 am
cvrx
AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs [Yahoo! Finance]
Medium
Report
AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs [Yahoo! Finance]
1/31
02:35 pm
cvrx
CVRx Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
Low
Report
CVRx Full Year 2023 Earnings: EPS Beats Expectations [Yahoo! Finance]
1/31
08:26 am
cvrx
CVRx Names Board Member Kevin Hykes President, CEO [MarketWatch]
Medium
Report
CVRx Names Board Member Kevin Hykes President, CEO [MarketWatch]
1/31
08:12 am
cvrx
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer [Yahoo! Finance]
Medium
Report
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer [Yahoo! Finance]
1/31
08:00 am
cvrx
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
Medium
Report
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
1/27
11:24 am
cvrx
CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
1/26
02:53 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Piper Sandler from $21.00 to $33.00. They now have an "overweight" rating on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Piper Sandler from $21.00 to $33.00. They now have an "overweight" rating on the stock.
1/26
11:22 am
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at JPMorgan Chase & Co. from $31.00 to $36.00. They now have an "overweight" rating on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at JPMorgan Chase & Co. from $31.00 to $36.00. They now have an "overweight" rating on the stock.
1/25
07:11 pm
cvrx
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
1/25
04:45 pm
cvrx
CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023 [Yahoo! Finance]
Low
Report
CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023 [Yahoo! Finance]
1/25
04:15 pm
cvrx
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results [Yahoo! Finance]
Low
Report
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results [Yahoo! Finance]
1/25
04:05 pm
cvrx
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Low
Report
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
1/22
01:21 pm
cvrx
CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Low
Report
CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]